Smith, C., Dunbar, P., Mirza, F., Palmowski, M., Shepherd, D., Gilbert, S., . . . Cerundolo, V. (2005). Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
Chicago-referens (17:e uppl.)Smith, C., et al. Recombinant Modified Vaccinia Ankara Primes Functionally Activated CTL Specific for a Melanoma Tumor Antigen Epitope in Melanoma Patients with a High Risk of Disease Recurrence. 2005.
MLA-referens (9:e uppl.)Smith, C., et al. Recombinant Modified Vaccinia Ankara Primes Functionally Activated CTL Specific for a Melanoma Tumor Antigen Epitope in Melanoma Patients with a High Risk of Disease Recurrence. 2005.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.